BioChemics, Inc. Announces Collaboration Agreement with Unilever

DANVERS, Mass.--(BUSINESS WIRE)--BioChemics, Inc. a company “enhancing drug delivery through biophysical modulation,” is pleased to announce the signing of a research collaboration agreement with Unilever, one of the world’s largest consumer goods companies, to utilize BioChemics’ proprietary topical delivery technology for the delivery of Unilever’s compounds.

MORE ON THIS TOPIC